glp-1 news november 2025 today drug Pipeline Update: GLP-1 Therapies May Benefit MPN

Co wane, nasila udzia tuszczw w procesach energetycznych ustroju, oszczdzajc tym samym inne substraty takie jak glikogen czy aminokwasy

To translate this to human parameters, we apply the FDAs Body Surface Area (BSA) normalization method

Recommended dosing of 1-2 mg subcutaneous injection 2-3x per week (6 mg/week total) compares to toxic dose estimated at ~22,500 mg (approximately 3,750 times higher than weekly dose)

Providers can sign up for early access here:

Furthermore, a double mutant lacking the operon encompassing both ahpD and spr0371 genes demonstrated enhanced resistance to H 2 O 2 concentrations of 9, 18, and 37 mM in the R6 strain [29]